Rare disease market work is not rare to us. The majority of NPP (new product planning)/strategic market planning work and market research we have conducted has been for rare disease therapeutics. We specialize in the creativity, drive and creativity required to find solutions in orphan drug markets which are usually poorly defined. Prevalence estimates are often debatable, prescribing information is often of low quality or non-existent and patients are often difficult to find. We excel in navigating these difficult markets and uncovering answers, insights and solutions.
(650) 308 4999